Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003823priorityCriticalpatent/ECSP003823A/en
Publication of ECSP003823ApublicationCriticalpatent/ECSP003823A/en
Los nuevos compuestos de bifenil sulfonamida los cuales son antagonistas del receptores de angiotensina y endotelina combinadas, se reivindican junto con los métodos de uso de tales compuestos en el tratamiento de las condiciones tales como hipertensión y otras enfermedades, así como también las composiciones farmacéuticas que contienen tales compuestos.The new biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed together with the methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutical compositions containing such compounds.
ECSP0038232000-12-132000-12-13
BIFENIL SULFONAMIDS AS ANTAGONISTS OF RECEIVERS OF ANGIOTENSIN ENDOTHELIA DUALES
ECSP003823A
(en)